Concepedia

Jingjing Zeng

JZ

Statistics

Publications

6

Citations

153

H-Index

6

Active since

2017

Affiliations

Ningbo No. 2 Hospital(Current)

Shenzhen Nanshan Center for Chronic Disease Control

University of Chinese Academy of Sciences

Jingjing Zeng is an author at Ningbo No. 2 Hospital specializing in myocardial ischemia-reperfusion injury, biochemistry, and ischemic heart disease.

ORCID

Publications per year

2017–2024

6

Publications

6

Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling

Jingjing Zeng, Hanqing Shi, Fangfang Ren et al. · Acta Pharmacologica Sinica · 2023 · 83 citations · Full text

, , +15

Identification of Serum Biomarkers of Ischemic Stroke in a Hypertensive Population Based on Metabolomics and Lipidomics

Tian Zhao, Qianqian Yan, Changyi Wang et al. · Neuroscience · 2023 · 24 citations

, , +15

Serum Olink Proteomics-Based Identification of Protein Biomarkers Associated with the Immune Response in Ischemic Stroke

Tian Zhao, Jingjing Zeng, Ruijie Zhang et al. · Journal of Proteome Research · 2024 · 14 citations

, , +17

[The effects and related mechanism of salvianolate on rats with myocardial ischemia-reperfusion injury].

Rongchuan Yue, Xinhong Yang, R Y Zhang et al. · PubMed · 2017 · 11 citations

, , +15

Plasma lipidomic profiling reveals six candidate biomarkers for the prediction of incident stroke in patients with hypertension

Jingjing Zeng, Ruijie Zhang, Tian Zhao et al. · Metabolomics · 2024 · 11 citations

, , +16

1–5 of 6